<?xml version="1.0" encoding="UTF-8"?><marc:collection xmlns:marc="http://www.loc.gov/MARC21/slim">
  <marc:record>
    <marc:leader>00000nam  2200000za 4500</marc:leader>
    <marc:controlfield tag="001">9.827351</marc:controlfield>
    <marc:controlfield tag="003">CaOODSP</marc:controlfield>
    <marc:controlfield tag="005">20221107144804</marc:controlfield>
    <marc:controlfield tag="007">cr |||||||||||</marc:controlfield>
    <marc:controlfield tag="008">170131s2016    oncd    o    f100 0 eng d</marc:controlfield>
    <marc:datafield tag="020" ind1=" " ind2=" ">
      <marc:subfield code="a">978-0-660-06774-2</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="040" ind1=" " ind2=" ">
      <marc:subfield code="a">CaOODSP</marc:subfield>
      <marc:subfield code="b">eng</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="043" ind1=" " ind2=" ">
      <marc:subfield code="a">n-cn---</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="086" ind1="1" ind2=" ">
      <marc:subfield code="a">HP40-171/2016E-PDF</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="111" ind1="2" ind2=" ">
      <marc:subfield code="a">Conference to Develop a Federal Framework on Lyme Disease</marc:subfield>
      <marc:subfield code="d">(2016 :</marc:subfield>
      <marc:subfield code="c">Ottawa, Ont.)</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="245" ind1="1" ind2="0">
      <marc:subfield code="a">Conference to Develop a Federal Framework on Lyme Disease, May 15-17, 2016 </marc:subfield>
      <marc:subfield code="h">[electronic resource] : </marc:subfield>
      <marc:subfield code="b">conference summary report.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="260" ind1=" " ind2=" ">
      <marc:subfield code="a">Ottawa : </marc:subfield>
      <marc:subfield code="b">Public Health Agency of Canada, </marc:subfield>
      <marc:subfield code="c">2016.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="300" ind1=" " ind2=" ">
      <marc:subfield code="a">ii, 26 p. : </marc:subfield>
      <marc:subfield code="b">col. charts</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">Issued also in French under title: Conférence pour élaborer un cadre fédéral relatif à la maladie de Lyme, du 15 au 17 mai 2016 : rapport sommaire de la conférence.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">Cover title.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="520" ind1=" " ind2=" ">
      <marc:subfield code="a">“As mandated by the Federal Framework on Lyme Disease Act, the Public Health Agency of Canada, on behalf of the Minister of Health, held a conference in May of 2016 in Ottawa, Canada. Participants included patients, representatives of provincial and federal health ministries, researchers, patient groups, health care professionals or other interested Canadians. Conference attendees participated both on-site and through an online interface. The three-day conference included a Public Forum on Day 1 that provided the opportunity for patients, caregivers and health professionals to share their experiences. Opening remarks at the Public Forum were provided by the Chief Public Health Officer for the Public Health Agency of Canada, the President of the Canadian Lyme Disease Foundation and the Past President of the Association of Medical Microbiology and Infectious Disease Canada. Day 2 of the conference began with opening remarks by the Minister of Health and the Green Party leader and Member of Parliament (whose private member’s Bill C-442 lead to the Act). During Days 2 and 3, domestic and international Lyme disease experts provided information and insight on current understanding, concerns and research related to Lyme disease surveillance, treatment, prevention, identification and management, as well as education and awareness. In breakout and plenary sessions during Days 2 and 3, participants had the opportunity to provide ideas for consideration in the development of the Federal Framework for Lyme Disease"--Intro., p. 1-2.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="692" ind1="0" ind2="7">
      <marc:subfield code="2">gccst</marc:subfield>
      <marc:subfield code="a">Diseases</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="692" ind1="0" ind2="7">
      <marc:subfield code="2">gccst</marc:subfield>
      <marc:subfield code="a">Health protection</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="692" ind1="0" ind2="7">
      <marc:subfield code="2">gccst</marc:subfield>
      <marc:subfield code="a">Conferences</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="710" ind1="2" ind2=" ">
      <marc:subfield code="a">Public Health Agency of Canada.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="775" ind1="0" ind2="8">
      <marc:subfield code="t">Conférence pour élaborer un cadre fédéral relatif à la maladie de Lyme, du 15 au 17 mai 2016 </marc:subfield>
      <marc:subfield code="w">(CaOODSP)9.827352</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="856" ind1="4" ind2="0">
      <marc:subfield code="q">PDF</marc:subfield>
      <marc:subfield code="s">1.30 MB</marc:subfield>
      <marc:subfield code="u">https://publications.gc.ca/collections/collection_2017/aspc-phac/HP40-171-2016-eng.pdf</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="986" ind1=" " ind2=" ">
      <marc:subfield code="a">160225</marc:subfield>
    </marc:datafield>
  </marc:record>
</marc:collection>
